Stock Events

Stock Events

Akero Therapeutics (AKRO) Q1 2025 Earnings

28FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-1.16

-1.04

-0.93

-0.81

Details

Expected EPS

-1.161275

Actual EPS

-0.99

Surprise EPS

0.17

Surprise Percent

+14.75%

Description

Akero Therapeutics (AKRO) has reported earnings of -0.99 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.